229 related articles for article (PubMed ID: 28873240)
21. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
22. Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer.
Togasaki K; Sugimoto S; Ohta Y; Nanki K; Matano M; Takahashi S; Fujii M; Kanai T; Sato T
Gastroenterology; 2021 Feb; 160(3):823-830. PubMed ID: 33217450
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological Characteristics and Survival Outcomes of Primary Signet Ring Cell Carcinoma in the Stomach: Retrospective Analysis of Single Center Database.
Liu X; Cai H; Sheng W; Yu L; Long Z; Shi Y; Wang Y
PLoS One; 2015; 10(12):e0144420. PubMed ID: 26642199
[TBL] [Abstract][Full Text] [Related]
25. Mixed Carcinoma as an Independent Prognostic Factor in Submucosal Invasive Gastric Carcinoma.
Park HK; Lee KY; Yoo MW; Hwang TS; Han HS
J Korean Med Sci; 2016 Jun; 31(6):866-72. PubMed ID: 27247494
[TBL] [Abstract][Full Text] [Related]
26. Advanced gastric carcinoma with signet ring cell histology.
Li C; Kim S; Lai JF; Hyung WJ; Choi WH; Choi SH; Noh SH
Oncology; 2007; 72(1-2):64-8. PubMed ID: 18004078
[TBL] [Abstract][Full Text] [Related]
27. The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours.
Bencivenga M; Treppiedi E; Dal Cero M; Torroni L; Verlato G; Iglesias M; Renaud F; Tomezzoli A; Castelli C; Piessen G; Pera M; de Manzoni G
J Surg Oncol; 2020 Jun; 121(7):1084-1089. PubMed ID: 32153051
[TBL] [Abstract][Full Text] [Related]
28. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of signet ring cell carcinoma of the stomach.
Kim JP; Kim SC; Yang HK
Surg Oncol; 1994 Aug; 3(4):221-7. PubMed ID: 7834113
[TBL] [Abstract][Full Text] [Related]
30. miR-99a-5p as Possible Diagnostic and Prognostic Marker in Patients With Gastric Cancer.
Saito R; Maruyama S; Kawaguchi Y; Akaike H; Shimizu H; Furuya S; Kawaida H; Ichikawa D
J Surg Res; 2020 Jun; 250():193-199. PubMed ID: 32078828
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic classification of gastric signet ring cell carcinoma and its relationship with K-ras mutation.
Xiong ZF; Shi J; Fu ZH; Wan HP; Tu LX
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28453172
[TBL] [Abstract][Full Text] [Related]
32. DNA aneuploidy in gastric carcinoma. Flow cytometric data related to survival, location, and histopathologic findings.
Flyger HL; Christensen IJ; Thorup J; Håkansson TU; Nørgaard T
Scand J Gastroenterol; 1995 Mar; 30(3):258-64. PubMed ID: 7770716
[TBL] [Abstract][Full Text] [Related]
33. Genetic lineage of poorly differentiated gastric carcinoma with a tubular component analysed by comparative genomic hybridization.
Peng DF; Sugihara H; Mukaisho K; Ling ZQ; Hattori T
J Pathol; 2004 Aug; 203(4):884-95. PubMed ID: 15258990
[TBL] [Abstract][Full Text] [Related]
34. Differential microRNA expression in signet-ring cell carcinoma compared with tubular adenocarcinoma of human gastric cancer.
Li FQ; Xu B; Wu YJ; Yang ZL; Qian JJ
Genet Mol Res; 2015 Jan; 14(1):739-47. PubMed ID: 25730011
[TBL] [Abstract][Full Text] [Related]
35. Transcriptome Analysis and the Prognostic Role of NUDC in Diffuse and Intestinal Gastric Cancer.
Jeong SH; Park M; Park SY; Park J; Kim TH; Lee YJ; Jung EJ; Ju YT; Jeong CY; Kim JY; Ko GH; Kim M; Nam KT; Goldenring JR
Technol Cancer Res Treat; 2021; 20():15330338211019501. PubMed ID: 34060350
[TBL] [Abstract][Full Text] [Related]
36. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological characteristics of RHOA mutations in a Central European gastric cancer cohort.
Röcken C; Behrens HM; Böger C; Krüger S
J Clin Pathol; 2016 Jan; 69(1):70-5. PubMed ID: 26251521
[TBL] [Abstract][Full Text] [Related]
38. Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.
Li-Chang HH; Kasaian K; Ng Y; Lum A; Kong E; Lim H; Jones SJ; Huntsman DG; Schaeffer DF; Yip S
BMC Cancer; 2015 Feb; 15():32. PubMed ID: 25656989
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples.
Dallol A; Buhmeida A; Al-Ahwal MS; Al-Maghrabi J; Bajouh O; Al-Khayyat S; Alam R; Abusanad A; Turki R; Elaimi A; Alhadrami HA; Abuzenadah M; Banni H; Al-Qahtani MH; Abuzenadah AM
J Transl Med; 2016 May; 14(1):118. PubMed ID: 27146902
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological study.
Ohashi R; Hayama A; Yanagihara K; Yamashita K; Sakatani T; Takei H; Naito Z
Diagn Pathol; 2016 Nov; 11(1):131. PubMed ID: 27846863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
